DK3140317T3 - Peptid-induceret nk-celleaktivering - Google Patents
Peptid-induceret nk-celleaktivering Download PDFInfo
- Publication number
- DK3140317T3 DK3140317T3 DK15722574.9T DK15722574T DK3140317T3 DK 3140317 T3 DK3140317 T3 DK 3140317T3 DK 15722574 T DK15722574 T DK 15722574T DK 3140317 T3 DK3140317 T3 DK 3140317T3
- Authority
- DK
- Denmark
- Prior art keywords
- peptide
- induced
- cell activation
- activation
- cell
- Prior art date
Links
- 230000006051 NK cell activation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1408264.8A GB201408264D0 (en) | 2014-05-09 | 2014-05-09 | Peptide-induced NK cell activation |
GB201502122A GB201502122D0 (en) | 2015-02-09 | 2015-02-09 | Peptide-induced NK cell activation |
PCT/GB2015/051370 WO2015170123A2 (en) | 2014-05-09 | 2015-05-08 | Peptide-induced nk cell activation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3140317T3 true DK3140317T3 (da) | 2020-07-20 |
Family
ID=53177692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15722574.9T DK3140317T3 (da) | 2014-05-09 | 2015-05-08 | Peptid-induceret nk-celleaktivering |
Country Status (5)
Country | Link |
---|---|
US (1) | US10995116B2 (da) |
EP (1) | EP3140317B1 (da) |
DK (1) | DK3140317T3 (da) |
ES (1) | ES2805047T3 (da) |
WO (1) | WO2015170123A2 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201519800D0 (en) * | 2015-11-10 | 2015-12-23 | Univ Southampton | Peptide-induced nk cell activation |
GB201903877D0 (en) | 2019-03-21 | 2019-05-08 | Univ Southampton | Peptide-induced nk cell activation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2685270C (en) * | 1998-05-13 | 2014-07-29 | Pharmexa Inc. | Expression vectors for stimulating an immune response and methods of using the same |
AU6226100A (en) * | 1999-07-19 | 2001-04-24 | Epimmune, Inc. | Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
EP1911461B1 (en) | 2000-10-19 | 2011-12-07 | Epimmune Inc. | HLA class I and II binding peptides and their uses |
EP2402026A3 (en) | 2002-09-13 | 2012-04-18 | Intercell AG | Method for isolating hepatitis C virus peptides |
US20080249283A1 (en) | 2004-04-30 | 2008-10-09 | Tomoya Miyakawa | Hla-Binding Peptides, Precursors Thereof, Dna Fragments and Recombinant Vectors that Code for Those Peptide Sequences |
JP2008509654A (ja) | 2004-06-01 | 2008-04-03 | イノジェネティックス・ナムローゼ・フェンノートシャップ | C型肝炎ウイルスに対するctlおよび/またはhtl応答を誘導するためのペプチド |
EP1652858A1 (en) | 2004-10-28 | 2006-05-03 | Innogenetics N.V. | Peptides for inducing a CTL and/or HTL response to hepatitis C virus |
-
2015
- 2015-05-08 EP EP15722574.9A patent/EP3140317B1/en active Active
- 2015-05-08 US US15/310,014 patent/US10995116B2/en active Active
- 2015-05-08 DK DK15722574.9T patent/DK3140317T3/da active
- 2015-05-08 ES ES15722574T patent/ES2805047T3/es active Active
- 2015-05-08 WO PCT/GB2015/051370 patent/WO2015170123A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015170123A3 (en) | 2016-02-04 |
EP3140317B1 (en) | 2020-04-15 |
WO2015170123A2 (en) | 2015-11-12 |
US10995116B2 (en) | 2021-05-04 |
ES2805047T3 (es) | 2021-02-10 |
US20170137466A1 (en) | 2017-05-18 |
EP3140317A2 (en) | 2017-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2014002755S1 (es) | Vehiculo | |
DK3110442T3 (da) | Modificerede meningokok-fhbp-polypeptider | |
DK3029959T3 (da) | Antenneenhed | |
DK3099791T3 (da) | Protein | |
BR112017000035A2 (pt) | conjunto de compartimento de articulação | |
DK3099793T3 (da) | Protein | |
DK3498588T3 (da) | Holdearrangement | |
DE102014000623A8 (de) | Halbhohlnietelement | |
DK3140317T3 (da) | Peptid-induceret nk-celleaktivering | |
GB201519800D0 (en) | Peptide-induced nk cell activation | |
DK3001076T3 (da) | Tilbageløbsforhindrer | |
ES1100207Y (es) | Válvula de alimentación | |
GB201408264D0 (en) | Peptide-induced NK cell activation | |
GB201502122D0 (en) | Peptide-induced NK cell activation | |
UA32044S (uk) | Чохол | |
DE112015004618A5 (de) | Garnitur | |
TH1401006762B (th) | เครื่องหั่น | |
TH1401006763B (th) | เครื่องหั่น | |
TH1601003330A (th) | เซลล์หุ่นยนต์ | |
DK3125735T3 (da) | Holderarrangement | |
FI10657U1 (fi) | Veitsi | |
TH1401005100B (th) | พนักพิงหลัง | |
UA28862S (uk) | Бахіла | |
UA30137S (uk) | Підлокітник | |
TH1601000676A (th) | เพพไทด์ |